Overview (04 Nov 2026)
Senores Pharmaceuticals Ltd
SENORES
INE0RB801010

Pharmaceuticals
Result was last declared on 14 May 2026
-10

Prev. Close
Previous Close
1147
Current Close
1137
Current High
1154.8
Current Low
1125
52 Week High
1599
52 Week Low
708.1
Resistance 1
1152.86
Resistance 2
1168.73
Support 1
1123.06
Support 2
1093.26
Std Deviation
9.38%
DMA 200
1116.60
DMA 50
1355.95
DMA 20
1252.97
Fundamentals and Ratios
Standalone
Trailing EPS
4.4
Forwad EPS
4.99
Trailing P/E
258.41
Forward P/E
228.01
PEG Ratio
38.60
Mkt. Cap (Cr)
Market Cap (Cr)
5236.29
Total Debt(Cr)
Tot. Debt(Cr)
394.49
Reserve (Cr)
956.93
Book Value
218.04
P/BV Ratio
5.21
ROCE(%)
3.00
ROE
4.00
Consolidated
Trailing EPS
26.39
Forwad EPS
31.23
Trailing P/E
43.08
Forward P/E
36.41
PEG Ratio
4.55
Mkt. Cap (Cr)
Market Cap (Cr)
5236.29
Total Debt(Cr)
Tot. Debt(Cr)
409.43
Reserve (Cr)
956.93
Book Value
217.57
P/BV Ratio
5.23
ROCE(%)
14.78
ROE
13.6900

 

Financial Result
Standalone
TypeSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue35.6526.9936.8128.7635.33106.09
Other Income14.769.5522.199.7811.3666.35
Total Income50.4136.5459.0038.5446.69172.44
Interest2.222.221.891.751.586.98
Expenditure-40.74-35.15-46.31-35.02-39.04-144.98
PBDT0.000.000.000.000.000.00
Depreciation-3.93-3.61-4.13-3.58-3.65-13.23
PBT9.671.3912.693.527.6527.46
Tax-1.95-0.36-4.21-0.87-1.22-7.21
Equity46.0546.0546.050.000.0046.05
OPM19.183.8021.5112.2421.6515.92
Net Profit7.721.038.482.656.4320.25
NPM15.312.8214.379.2118.211.74
EPS1.680.221.841.981.44.4
Consolidated
TypeSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue192.33180.21175.19174.56161.76632.63
Other Income8.942.8117.673.785.4147.06
Total Income201.27183.02192.86178.34167.17679.69
Interest8.777.178.465.336.1925.03
Expenditure-153.69-143.56-145.46-133.74-126.53-520.59
PBDT0.000.000.000.000.000.00
Depreciation-10.25-9.94-9.30-7.85-8.09-31.25
PBT47.5839.4647.4044.6040.64159.10
Tax-10.98-9.01-10.73-11.02-10.52-37.57
Equity46.0546.0546.050.0046.0546.05
OPM23.6421.5624.5825.0124.3123.41
Net Profit36.630.4536.6733.5830.12121.53
NPM18.1816.6419.0118.8318.0217.88
EPS8.856.617.967.296.5426.39
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings